
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Hepar
Description
Glycomic Therapeutics Global Market Report 2023
Including: 1) By Class: Isolated; Synthetic2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And BCovering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
Glycomic Therapeutics Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on glycomic therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for glycomic therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glycomic therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Class: Isolated; Synthetic
2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids; Other Structures
3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons; Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B; Other Indications
Companies Mentioned: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Glycomic Therapeutics Market Characteristics
- 3. Glycomic Therapeutics Market Trends And Strategies
- 4. Glycomic Therapeutics Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On Online Therapy Services Market
- 4.2. Ukraine-Russia War Impact On Online Therapy Services Market
- 4.3. COVID-19 Impact On Online Therapy Services Market
- 5.1. Global Glycomic Therapeutics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
- 5.2. Global Glycomic Therapeutics Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
- 5.3. Global Glycomic Therapeutics Market Drivers and Restraints
- 5.3.1. Drivers Of The Market
- 5.3.2. Restraints Of The Market
- 6. Glycomic Therapeutics Market Segmentation
- 6.1. Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Isolated
- Synthetic
- 6.2. Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Glycoproteins
- Targeting Sialic Acid
- Proteoglycans
- Targeting Glycosaminoglycans
- Glycosylphosphatidylinositol (Gpi)-Anchored Proteins And Heparin Based Glycans
- Targeting Glycosphingolipids
- Other Structures
- 6.3. Global Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Inhibits Neuraminidase
- Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate
- Erythropoietin And Enzyme Replacement Therapy (Ert)
- Tissue Plasminogen Activator
- Inhibits Glucosylceramide Synthase
- Interleukin 1, 2 And 3
- Beta And Gamma Interferons
- Other Mode Of Action
- 6.4. Global Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Thrombosis And Chemoprophylaxis
- Anaemia
- Anti-Adhesive And Anti-Inflammatory
- Cataracts
- Gaucher’S Disease
- Mps-1 And Iv
- Cancer
- Alzheimer’S Disease
- Influenza Type A And B
- Other Indications
- 7. Glycomic Therapeutics Market Regional And Country Analysis
- 7.1. Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 7.2. Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8. Asia-Pacific Glycomic Therapeutics Market
- 8.1. Asia-Pacific Glycomic Therapeutics Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.3. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.4. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 9. China Glycomic Therapeutics Market
- 9.1. China Glycomic Therapeutics Market Overview
- 9.2. China Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.3. China Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.4. China Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 10. India Glycomic Therapeutics Market
- 10.1. India Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.2. India Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.3. India Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11. Japan Glycomic Therapeutics Market
- 11.1. Japan Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.2. Japan Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.3. Japan Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12. Australia Glycomic Therapeutics Market
- 12.1. Australia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.2. Australia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.3. Australia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13. Indonesia Glycomic Therapeutics Market
- 13.1. Indonesia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.2. Indonesia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.3. Indonesia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14. South Korea Glycomic Therapeutics Market
- 14.1. South Korea Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.2. South Korea Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.3. South Korea Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15. Western Europe Glycomic Therapeutics Market
- 15.1. Western Europe Glycomic Therapeutics Market Overview
- 15.2. Western Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.3. Western Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.4. Western Europe Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16. UK Glycomic Therapeutics Market
- 16.1. UK Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.2. UK Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.3. UK Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17. Germany Glycomic Therapeutics Market
- 17.1. Germany Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.2. Germany Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.3. Germany Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18. France Glycomic Therapeutics Market
- 18.1. France Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.2. France Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.3. France Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19. Italy Glycomic Therapeutics Market
- 19.1. Italy Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.2. Italy Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.3. Italy Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20. Spain Glycomic Therapeutics Market
- 20.1. Spain Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.2. Spain Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.3. Spain Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21. Eastern Europe Glycomic Therapeutics Market
- 21.1. Eastern Europe Glycomic Therapeutics Market Overview
- 21.2. Eastern Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.3. Eastern Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.4. Eastern Europe Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22. Russia Glycomic Therapeutics Market
- 22.1. Russia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.2. Russia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.3. Russia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23. North America Glycomic Therapeutics Market
- 23.1. North America Glycomic Therapeutics Market Overview
- 23.2. North America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.3. North America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.4. North America Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24. USA Glycomic Therapeutics Market
- 24.1. USA Glycomic Therapeutics Market Overview
- 24.2. USA Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.3. USA Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.4. USA Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25. Canada Glycomic Therapeutics Market
- 25.1. Canada Glycomic Therapeutics Market Overview
- 25.2. Canada Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.3. Canada Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.4. Canada Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26. South America Glycomic Therapeutics Market
- 26.1. South America Glycomic Therapeutics Market Overview
- 26.2. South America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.3. South America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.4. South America Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27. Brazil Glycomic Therapeutics Market
- 27.1. Brazil Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.2. Brazil Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.3. Brazil Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28. Middle East Glycomic Therapeutics Market
- 28.1. Middle East Glycomic Therapeutics Market Overview
- 28.2. Middle East Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.3. Middle East Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.4. Middle East Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29. Africa Glycomic Therapeutics Market
- 29.1. Africa Glycomic Therapeutics Market Overview
- 29.2. Africa Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.3. Africa Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.4. Africa Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 30. Glycomic Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Glycomic Therapeutics Market Competitive Landscape
- 30.2. Glycomic Therapeutics Market Company Profiles
- 30.2.1. F Hoffmann-La Roche Ltd.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Bayer AG
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Sanofi SA
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Thermo Fisher Scientific Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. GlaxoSmithKline plc
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 31. Glycomic Therapeutics Market Other Major And Innovative Companies
- 31.1. Merck KGaA
- 31.2. ICON plc
- 31.3. Agilent Technologies Inc.
- 31.4. AMS Bio
- 31.5. Shimadzu Corporation
- 31.6. Waters Corporation
- 31.7. Bruker Corporation
- 31.8. BioMarin Pharmaceutical Inc.
- 31.9. Bio Techne Corp.
- 31.10. Promega Corporation
- 31.11. Halozyme Therapeutics Inc.
- 31.12. Takara Bio Inc.
- 31.13. Vector Laboratories
- 31.14. New England Biolabs Inc.
- 31.15. Protalix Biotherapeutics Inc.
- 32. Global Glycomic Therapeutics Market Competitive Benchmarking
- 33. Global Glycomic Therapeutics Market Competitive Dashboard
- 34. Key Mergers And Acquisitions In The Glycomic Therapeutics Market
- 35. Glycomic Therapeutics Market Future Outlook and Potential Analysis
- 35.1 Glycomic Therapeutics Market In 2027 - Countries Offering Most New Opportunities
- 35.2 Glycomic Therapeutics Market In 2027 - Segments Offering Most New Opportunities
- 35.3 Glycomic Therapeutics Market In 2027 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.